Biotechnology Council of New Jersey Elects New Officers

February 23, 2007
BioPharm International Editors

The Biotechnology Council of New Jersey (Trenton, NJ, www.biotechnj.org) has elected three new members to its board of trustees.

The Biotechnology Council of New Jersey (Trenton, NJ, www.biotechnj.org) has elected three new members to its board of trustees. The new members are: Ulrich M. Grau, PhD, president and CEO of Lux Biosciences, Inc.; Dan Greenleaf, president and CEO of VioQuest Pharmaceuticals, Inc.; and John Maki, president and CEO of Vicus Therapeutics.